KBI Biopharma is expanding its biopharmaceutical manufacturing capacity at both its Durham, NC, and Boulder, CO, facilities. It is investing approximately $30 million on the two site expansion projects scheduled for completion later this year. KBI is building commercial mammalian cell culture manufacturing capability within its Durham facility, which also houses cGMP cell culture manufacturing lines for clinical production. KBI’s development capabilities and track record of success in clinica...